<?xml version="1.0" encoding="UTF-8"?>
<p>Among the 120 individuals evaluated, 22/120 (18.3%) were anti-CHIKV IgG-positive, and 06/120 (5.0%) were anti-CHIKV IgM-positive. Three samples were borderline on the test used. Among the six patients who had CHIKV-specific IgM, four (66.7%) also showed CHIKV specific-IgG antibodies, for an overall prevalence of 20% (95% CI, 15.4â€“35.7%) (
 <xref rid="pntd.0005319.t002" ref-type="table">Table 2</xref>).
</p>
